Harel Insurance Investments & Financial Services Ltd. Acquires New Shares in Phreesia, Inc. (NYSE:PHR)


Share on StockTwits

Harel Insurance Investments & Financial Services Ltd. acquired a new stake in Phreesia, Inc. (NYSE:PHR) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,736 shares of the company’s stock, valued at approximately $875,000.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Strs Ohio raised its holdings in shares of Phreesia by 290.3% in the first quarter. Strs Ohio now owns 12,100 shares of the company’s stock valued at $630,000 after acquiring an additional 9,000 shares in the last quarter. UBS Asset Management Americas Inc. raised its holdings in shares of Phreesia by 14.3% in the fourth quarter. UBS Asset Management Americas Inc. now owns 21,600 shares of the company’s stock valued at $1,172,000 after acquiring an additional 2,700 shares in the last quarter. Hsbc Holdings PLC raised its holdings in shares of Phreesia by 21.9% in the fourth quarter. Hsbc Holdings PLC now owns 19,493 shares of the company’s stock valued at $1,055,000 after acquiring an additional 3,503 shares in the last quarter. Principal Financial Group Inc. bought a new stake in shares of Phreesia in the fourth quarter valued at about $457,000. Finally, Truist Financial Corp raised its holdings in shares of Phreesia by 19.5% in the fourth quarter. Truist Financial Corp now owns 16,085 shares of the company’s stock valued at $873,000 after acquiring an additional 2,625 shares in the last quarter. Hedge funds and other institutional investors own 75.38% of the company’s stock.

In related news, CFO Thomas Altier sold 76,272 shares of the company’s stock in a transaction that occurred on Thursday, February 18th. The stock was sold at an average price of $71.96, for a total value of $5,488,533.12. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Edward L. Cahill sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, February 18th. The shares were sold at an average price of $72.00, for a total value of $720,000.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 151,888 shares of company stock worth $10,105,096. 28.20% of the stock is owned by insiders.

A number of brokerages have commented on PHR. SVB Leerink reduced their target price on shares of Phreesia from $85.00 to $75.00 and set an “outperform” rating for the company in a report on Thursday, April 1st. Robert W. Baird began coverage on shares of Phreesia in a report on Thursday, April 1st. They issued an “outperform” rating and a $60.00 target price for the company. Piper Sandler reiterated an “overweight” rating and issued a $58.00 target price (up from $56.00) on shares of Phreesia in a report on Wednesday, March 31st. Zacks Investment Research downgraded shares of Phreesia from a “hold” rating to a “sell” rating in a report on Wednesday, April 14th. Finally, Needham & Company LLC boosted their target price on shares of Phreesia from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday, January 14th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and ten have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $53.64.

Shares of PHR stock opened at $50.62 on Tuesday. The stock’s 50-day simple moving average is $53.39 and its 200-day simple moving average is $54.50. The firm has a market capitalization of $2.27 billion, a price-to-earnings ratio of -84.37 and a beta of 1.42. Phreesia, Inc. has a fifty-two week low of $24.21 and a fifty-two week high of $81.59. The company has a debt-to-equity ratio of 0.09, a quick ratio of 7.24 and a current ratio of 7.24.

Phreesia (NYSE:PHR) last issued its earnings results on Wednesday, March 31st. The company reported ($0.10) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.15) by $0.05. Phreesia had a negative return on equity of 16.07% and a negative net margin of 16.37%. As a group, equities analysts forecast that Phreesia, Inc. will post -0.67 earnings per share for the current year.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.

Read More: What are high-yield dividend stocks?

Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc. (NYSE:PHR).

Institutional Ownership by Quarter for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.